Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ASA Gold and Precious Metals Ltd C.ASA


Primary Symbol: ASA

ASA Gold and Precious Metals Limited is a non-diversified, closed-end investment company. The Company's investment objective is long-term capital appreciation primarily through investing in companies engaged in the exploration for, development of projects or mining of precious metals and minerals. The Company invests approximately 80% of its total assets in common shares or securities convertible into common shares of companies engaged, directly or indirectly, in the exploration, mining or processing of gold, silver, platinum, diamonds or other precious minerals; held as bullion or other direct forms of gold, silver, platinum or other precious minerals; in instruments representing interests in gold, silver, platinum or other precious minerals, and/or in securities of investment companies, including exchange traded funds, or other securities. The Company’s investment adviser is Merk Investments LLC.


NYSE:ASA - Post by User

Comment by TheBananaManon Apr 03, 2019 3:24pm
61 Views
Post# 29578019

RE:RE:RE:RE:RE:RE:Labs Financials vs. Valens Financials

RE:RE:RE:RE:RE:RE:Labs Financials vs. Valens FinancialsYou are right my bad ! Anyways tired to argue who is best and bla bla... See you all at 10$ for theses two stocks...

lscfa wrote: Do more dd. LABS got its license in November so it could not start producing and selling oil until late in the quarter. Also, how is a $35 million deal ($48 mliion with option) over 12 months a one shot deal? Obviously the client is buying oil from LABS each month and could extend the contract. 1 year, 2 year, 3 year contracts. BFD.

p.s. your incorrect about LABS having a higher cost structure....

 

SG&A

Valens 

Medipharm

Q4

4,901,215

3,103,000

Q3

2,443,425

1,972,776

Q2

2,555,254

1,605,584

Q1

3,882,298

1,344,921

 





TheBananaMan wrote: Exactly what I think and have been saying... For me VGW is THE long term play here... That 10 million from Labs was one shot deal and same with their other 35 million or so, one shot deals....... TBM
BigBaller11 wrote: It’s hilarious how people think Labs is doing better. 

Labs CEO pat tweeted out that they did 10M in December. 

Full quarter was only 10.2M. So what was done for the other 2 months. 

Valens is in a different league. Zero risk / zero liability.  

If Valens wanted to purchase product they would. But clearly they are not. Makes no sense to. 

 




<< Previous
Bullboard Posts
Next >>